Table 3. Sensitivity analyses.
| In models without other medications | In models adjusting for other medications* | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | p-value | 95% CI | OR | p-value | 95% CI | ||||
| Overall | 0.60 | 0.00 | 0.44 | 0.81 | 0.54 | 0.00 | 0.39 | 0.73 | |
| In subgroups | |||||||||
| Age | 50–64 (n = 2,338) | 0.62 | 0.05 | 0.39 | 1.00 | 0.57 | 0.03 | 0.34 | 0.96 |
| 65–74 (n = 872) | 0.64 | 0.22 | 0.32 | 1.30 | 0.61 | 0.14 | 0.31 | 1.18 | |
| 75+ (n = 672) | 0.62 | 0.06 | 0.37 | 1.03 | 0.45 | 0.01 | 0.26 | 0.79 | |
| Diagnosis of DM, HTN or CVD (n = 1,896) | 0.70 | 0.06 | 0.49 | 1.02 | 0.65 | 0.02 | 0.44 | 0.94 | |
| With BMI information (n = 7,097) | 0.64 | 0.01 | 0.47 | 0.89 | 0.59 | 0.00 | 0.42 | 0.82 | |
*Included B Blockers, Calcium Channel Blockers, Diuretics, Alpha Blockers, Statins, Asthma/COPD Medications, Diabetes Medications, NSAIDs, Steroids, Other Immunomodulatory Medications.